We know much more about rapid COVID testing now than ever before. Learn three key lessons in acute care diagnostics from the pandemic.
As a medical device manufacturer, Response Biomedical (RBM) has been closely monitoring the research regarding the detection of SARS-CoV-2.
Since the onset of the pandemic, rapid testing has gone through many changes. Discover how POC testing has affected the healthcare system and what lies ahead.
Response Biomedical launches COVID-19 (SARS-CoV-2) antigen test for countries accepting CE mark, to support the growing demand for testing. Response Biomedical Corp. (Response), a global
As a medical device manufacturer, we have been closely monitoring the research that is currently being conducted into the detection of SARS-CoV-2. Response Biomedical’s purpose
Response Biomedical Corp. is proud to be part of Canada’s fight against COVID-19 by developing a COVID-19 Antibody (Serology) test on the RAMP® platform. The
Response Biomedical is excited to be a part of Next Generation Manufacturing Canada’s (NGen) fight against COVID-19 by developing a 15 minute COVID-19 test on
As the amount of available information and research into COVID-19 is constantly changing, we wish to continue to provide you with updated information. Please find
As a medical device manufacturer, we have been closely monitoring the research that is currently being conducted into the detection of COVID-19. Response Biomedical’s purpose
Not all products are available in all regions. Contact us for availability in specific markets.
